Discontinuation of first-line molecular-targeted therapy and prognosis in patients with metastatic renal cell carcinoma: Impact of disease progression vs. adverse events

Ryosuke Ando, Kiyoshi Takahara, Toshiki Ito, Kent Kanao, Ikuo Kobayashi, Ryoichi Shiroki, Makoto Sumitomo, Hideaki Miyake, Takahiro Yasui

研究成果: Article査読

フィンガープリント

「Discontinuation of first-line molecular-targeted therapy and prognosis in patients with metastatic renal cell carcinoma: Impact of disease progression vs. adverse events」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

Medicine & Life Sciences